Trimel is a specialty pharmaceutical company developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders.
A New Drug Application for CompleoTRT™, the Company's novel product for the treatment of male hypogonadism, or "Low T", has been submitted to the U.S. Food and Drug Adminitration for review.
Tefina™, a product under development for female orgasmic disorder, is being clinically tested in an ongoing phase II trial involving 240 women in the U.S., Canada and Australia.
TriVair™ is an award-winning single-use unit-dose dry powder inhalation drug delivery platform with applications for both nasal and pulmonary dosing
© 2014 by Trimel Pharmaceuticals Corporation